Efficacy of CAR-T immunotherapy in MET overexpressing tumors not eligible for anti-MET targeted therapy
Work
Year: 2022
Type: article
Abstract: Aberrant activation of the MET receptor in cancer is sustained by genetic alterations or, more frequently, by transcriptional upregulations. A fraction of MET-amplified or mutated tumors are sensible ... more
Institutions Candiolo Cancer Institute, Istituti di Ricovero e Cura a Carattere Scientifico, Vita-Salute San Raffaele University, Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele, IFOM +1 more
Cites: 71
Cited by: 12
Related to: 10
FWCI: 1.749
Citation percentile (by year/subfield): 80.78
Topic: CAR-T cell therapy research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Sustainable Development Goal Good health and well-being
Open Access status: gold
APC paid (est): $2,919
Funders Ministero della Salute, Ministero della Salute, Associazione Italiana per la Ricerca sul Cancro, Associazione Italiana per la Ricerca sul Cancro, Associazione Italiana per la Ricerca sul Cancro +1 more
Grant IDS RCR-2019-23669115, ricerca corrente 2018-2021, IG 2017 – ID 20210, IG 2019 - ID 23820, 5 per Mille 2018 - ID 21052 +1 more